14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARQT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Arcutis Biotherapeutics Inc stock after gaining 0.114%
(Updated on Apr 24, 2024)

Sell candidate since Apr 23, 2024 Gain 0.11% PDF

The Arcutis Biotherapeutics Inc stock price gained 0.114% on the last trading day (Wednesday, 24th Apr 2024), rising from $8.74 to $8.75. During the last trading day the stock fluctuated 4.12% from a day low at $8.74 to a day high of $9.10. The price has fallen in 7 of the last 10 days and is down by -29.09% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 187 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $15.57 million.

Given the current short-term trend, the stock is expected to rise 51.77% during the next 3 months and, with a 90% probability hold a price between $13.28 and $20.36 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARQT Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arcutis Biotherapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.33 and $10.26. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 08, 2024, and so far it has fallen -30.17%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Arcutis Biotherapeutics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $7.97 and $6.64. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Arcutis Biotherapeutics Inc finds support just below today's level at $7.97. If this is broken, then the next support from accumulated volume will be at $6.64 and $6.57.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.360 between high and low, or 4.12%. For the last week, the stock has had daily average volatility of 8.08%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARQT) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Arcutis Biotherapeutics Inc to open at $8.86, and during the day (based on 14 day Average True Range), to move between $7.92 and $9.58, which gives a possible trading interval of +/-$0.83 (+/-9.48%) up or down from last closing price. If Arcutis Biotherapeutics Inc takes out the full calculated possible swing range there will be an estimated 18.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.30 (6.29%) than the support at $7.97 (8.91%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Arcutis Biotherapeutics Inc stock A Buy?

The Arcutis Biotherapeutics Inc stock holds several negative signals and despite the positive trend, we believe Arcutis Biotherapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.426 Sell Candidate Unchanged

Predicted Opening Price for Arcutis Biotherapeutics Inc of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$8.86 ( 1.30%) $8.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARQT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.22 5.41 %
R2 9.09 3.84 %
R1 9.00 2.87 %
Current price: 8.75
Support S1 8.73 -0.276 %
S2 8.64 -1.25 %
S3 8.50 -2.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.66 21.83 %
R2 10.28 17.49 %
R1 9.30 6.29 %
Current price 8.75
Support S1 7.97 -8.91%
S2 6.64 -24.11%
S3 6.57 -24.91%

FAQ

What is the symbol for Arcutis Biotherapeutics Inc Stock and on which exchange is it traded?
The symbol for Arcutis Biotherapeutics Inc is ARQT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arcutis Biotherapeutics Inc Stock?
The Arcutis Biotherapeutics Inc stock holds several negative signals and despite the positive trend, we believe Arcutis Biotherapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Arcutis Biotherapeutics Inc Stock?
Arcutis Biotherapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcutis Biotherapeutics Inc Stock.

What's the current price of Arcutis Biotherapeutics Inc Stock?
As of the end of day on the Apr 24, 2024, the price of an Arcutis Biotherapeutics Inc (ARQT) share was $8.75.

What is the 52-week high and low for Arcutis Biotherapeutics Inc Stock?
The 52-week high for Arcutis Biotherapeutics Inc Stock is $15.21 and the 52-week low is $1.76.

What is the market capitalization of Arcutis Biotherapeutics Inc Stock?
As of the Apr 24, 2024, the market capitalization of Arcutis Biotherapeutics Inc is 1.005B.

When is the next earnings date for Arcutis Biotherapeutics Inc?
The upcoming earnings date for Arcutis Biotherapeutics Inc is May 14, 2024.
Click to get the best stock tips daily for free!

About Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp ... ARQT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT